– CANADA, Kitchener – Kenota Health today announced the appointments of Ruth Abdulmassih and Dennis Flannelly to its Board of Directors.
About Ruth Abdulmassih
Ruth Abdulmassih is the CEO of Alternative Biomedical Solutions a leader in laboratory technologies and services. Abdulmassih previously spent 23 years with Abbott, 13 years of which were in the diagnostic division. Abdulmassih has extensive experience in industries governed by rigorous compliance requirements and demanding technical expertise and has managed P&Ls, expanded businesses internationally, and has deep experience in mergers & acquisitions. Abdulmassih also brings extensive board experience having served as a director at Resurge International and ABS.
“I’m excited by the work that Kenota is doing. Moving allergy testing to the point-of-care will assist allergists and improve the patient experience. Ultimately it has the potential to unlock untapped demand among untested patients. I look forward to assisting the company in capitalizing on this opportunity,” said Ruth Abdulmassih. “
About Dennis Flannelly
Dennis Flannelly is the Head of Precision Medicine for US Oncology at Merck, known as MSD outside of the United States and Canada. Flannelly has strong experience in the development and introduction of diagnostic solutions in the immunology space and brings a unique perspective having led successful businesses involved in both biotech and pharma for over 20 years. Before joining Merck, Flannelly was VP and GM of Immunodiagnostics at PerkinElmer, as well as the Global Head of Clinical Marketing for Thermo Fisher Scientific’s Immunodiagnostics business.
About Kenota Health
Kenota Health is a medical technology company based in Waterloo, Canada, with a plan to elevate healthcare with the world’s best data and testing. Their first product is a rapid system to test for patients’ allergic sensitizations in the clinic within 30 minutes, with a primary focus on the U.S. and Canadian markets. Kenota’s team is composed of scientists, engineers, and business operators, many of whom have commercialized dozens of tests in their career and received approvals from the FDA, EU, Health Canada, as well as several countries around Asia and MENA.
For more information: https://kenota.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
